Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous SVF Cells for Knee Osteoarthritis
NCT02967874Phase 2Completed
- Sponsor
- Russian Academy of Sciences
- Start
- Mar 2016
- Primary completion
- Jun 2019
- Countries
- 1
01
Overview
Phase 2, open-label trial in osteoarthritis (OA) (2 arms), sponsored by Russian Academy of Sciences. Primary endpoint: Number of patients with adverse events at 12 months. Started Mar 2016; status: completed.
02
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02967874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02967874.